Sector
PharmaceuticalsOpen
₹1,129.3Prev. Close
₹1,129.3Turnover(Lac.)
₹5.06Day's High
₹1,129.3Day's Low
₹1,111.352 Week's High
₹1,87052 Week's Low
₹802Book Value
₹561.26Face Value
₹10Mkt Cap (₹ Cr.)
777.45P/E
29.39EPS
38.38Divi. Yield
0.0922 May 2024
12:00 AM
Dividend
Dividend Amount: 1
Record Date: 25 Jun, 2024
10 Jun 2024
12:00 AM
AGM
Announcement Date: 10 Jun, 2024
5 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 5.82 | 5.77 | 5.77 | 5.73 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 207.79 | 185.29 | 160.38 | 138.21 |
Net Worth | 213.61 | 191.06 | 166.15 | 143.94 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 203.66 | 226.32 | 136.32 | 111.22 |
yoy growth (%) | -10.01 | 66.01 | 22.56 | -7.1 |
Raw materials | -134.03 | -147.23 | -87.98 | -79.26 |
As % of sales | 65.8 | 65.05 | 64.53 | 71.26 |
Employee costs | -14.38 | -14.1 | -12.36 | -11.05 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 27.01 | 34.95 | 13.77 | 7.96 |
Depreciation | -6.02 | -5.88 | -5.57 | -5.79 |
Tax paid | -6.8 | -8.65 | -3.67 | -0.58 |
Working capital | -3.24 | 29.95 | 17.25 | -4.15 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -10.01 | 66.01 | 22.56 | -7.1 |
Op profit growth | -16.81 | 127.66 | 89.81 | -32.25 |
EBIT growth | -22.44 | 143.4 | 65.89 | -18.1 |
Net profit growth | -23.15 | 160.4 | 36.86 | 14.35 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 340.38 | 261.22 | 217.98 | 212.01 | 204.64 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 340.38 | 261.22 | 217.98 | 212.01 | 204.64 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 11.62 | 4.68 | 11.74 | 7.78 | 8.67 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,647.35 | 92.29 | 3,95,254.45 | 2,000.46 | 0.97 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,493.2 | 78.03 | 1,72,374.06 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,483.15 | 24.33 | 1,19,795.19 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,326.4 | 20.69 | 1,10,689.83 | 1,200.7 | 0.6 | 5,546.3 | 345.79 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,167.95 | 56.27 | 1,07,213.01 | 474 | 1.01 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
Bharat Kumar R Desai
Executive Director
Hemang Jayendrabhai Shah
Non Executive Director
Shaileshkumar Ghabhawala
Independent Director
Zankhana Sheth
Independent Director
Mukesh Patel
Non Executive Director
Sanjay Shah
Survey No 144 & 146 Haripura,
Jarod Samlaya Road Tal Savli,
Gujarat - 391520
Tel: 91-2667-251679
Website: http://www.bplindia.in
Email: info@bplindia.in
205/206 Sterling Cen,
R C Dutt Road, Alkapuri,
Vadodara - 390007
Tel: 91-0265-2333667
Website: -
Email: -
Summary
Bharat Parenterals Ltd. was incorporated on Sep.92 in Gujarat and promoted by Ramesh Desai and Bharat Desai. The Company is engaged in the business of manufacturing drugs, pharmaceutical formulations ...
Read More
Reports by Bharat Parenterals Ltd
What is the Bharat Parenterals Ltd share price today?
What is the Market Cap of Bharat Parenterals Ltd?
What is the PE and PB ratio of Bharat Parenterals Ltd?
What is the 52 Week High and Low of Bharat Parenterals Ltd?
What is the CAGR of Bharat Parenterals Ltd?
What is the shareholding pattern of Bharat Parenterals Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.